Medication adherence part one: Understanding and assessing the problem

Journal of the American Association of Nurse Practitioners

Volumn 26, Issue 1, 2014, Pages 49-55

  Neiheisel, Mary B ^a,b   Wheeler, Kathy J ^c   Roberts, Mary Ellen ^d  

^a UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

^b Faith House Inc   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

^d SETON HALL UNIVERSITY   (United States)

Author keywords

Adherence; Medication adherence; Medication nonadherence; Nonadherence

Indexed keywords

HUMAN; MEDICATION COMPLIANCE; NURSE ATTITUDE; PSYCHOLOGY;

HUMANS; MEDICATION ADHERENCE; NURSE'S ROLE;

EID: 84898445670     PISSN: 23276886     EISSN: 23276924     Source Type: Journal    
DOI: 10.1002/2327-6924.12099     Document Type: Review

References (53)

1. Asche, C., LaFleur, J., & Conner, C. (2011). A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics, 33(1), 74-109.
2. Bailey, C. J., & Kodack, M. (2011). Patient adherence to medication requirements for therapy of type 2 diabetes. International Journal of Clinical Practice, 65(3), 314-322.
3. Balkrishnan, R. (2005). The importance of medication adherence in improving chronic-disease related outcomes: What we know and what we need to further know. Medical Care, 43(6), 517-520.
4. Barber, N., Parsons, J., Clifford, S., Darracott, R., & Horne, R.(2004). Patients' problems with new medication for chronic conditions. Quality and Safety in Health Care, 13(3), 172-175.
5. Bogh, E. (2004). Compliance to drug treatment in clinical trials. Business Briefing: Pharmatech, 1, 1-3. Retrieved from http://www.yumpu.com/en/document/view/7773166/compliance-to-drug-treatment-in-clinical-trials-touch-briefings
6. Bosworth, H. B., Granger, B. B., Mendys, P., Brindis, R., Burkholder, R., Czajkowski, M., ...Grander, C. B. (2011). Medication adherence: A call for action. American Heart Journal, 162(3), 412-424.
7. Brunton, S. A. (2011). Improving medication adherence in chronic disease management. Journal of Family Practice, 60(4 Suppl. Improving), S1-S8.
8. Burnier, M. (2006). Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. American Journal of Hypertension, 19(11), 1190-1196.
9. Caro, J. J., Salas, M., Speckman, J., Raggio, G., & Jackson, J. (1999). Persistence with treatment for hypertension in actual practice. Canadian Medical Association Journal, 160, 31-37.
10. Cramer, J. A., & Rosenheck, R. (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Service, 49(2), 196-201.
11. Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: Terminology and definitions. Value in Health, 11, 44-47.
12. Cramer, J. A., Scheyer, R. D., & Mattson, R. H. (1990). Compliance declines between clinic visits. Archives of Internal Medicine, 150(7), 1509-1510.
13. DiMatteo, M. R. (2004). Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42(3), 200-209.
14. DiMatteo, M. R., Giordani, M., Lepper, H., & Croghan, T. (2002). Patient adherence and medical treatment outcomes: A meta-analysis. Medical Care, 40(9), 794-811.
15. Dittmer, C., Roeder, K., Hoellen, F., Salehin, D., Thill, M., & Fischer, D. (2011). Compliance to adjuvant therapy in breast cancer patients. European Journal of Gynaecological Oncology, 32(3), 280-282.
16. Doggrell, S. A. (2010). Adherence to medicines in the older-aged with chronic conditions: Does intervention by an allied health professional help? Drugs and Aging, 27(3), 239-254.
17. Dunbar, S. B., Clark, P., Quinn, C., Gary, R., & Kaslow, N. (2008). Family influences on heart failure self-care and outcomes. Journal of Cardiovascular Nursing, 23(3), 258-265.
18. Ettinger, M. P., Gallagher, R., & MacCosbe, P. E. (2006). Medication persistence with weekly versus daily doses of orally administered bisphosphonates. Endocrine Practice, 12(5), 522-528.
19. Fitzgerald, A. A., & Powers, J. D. (2011). Impact of non-adherence on hospitalizations and mortality in heart failure. Journal of Cardiac Failure, 17, 664-669.
20. Forissier, T. (2011). Patient adherence: The next frontier in patient care. New York: Capgemini Consulting.
21. Frishman, W. H. (2007). Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiology Review, 15(5), 257-263.
22. Gehi, A. K. (2007). Self-reported medication adherence and cardiovascular events in patients with coronary heart disease. Archives of Internal Medicine, 167(16), 1798-1803.
23. Gehi, A. K., Ali, S, Na, B., & Wooley, M. (2007). Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: The heart and soul study. Archives of Internal Medicine, 167(16), 1798-1803.
24. Giovannetti, E. R., Wolff, J., Frick, K., & Boult, K. (2009). Construct validity of the Work Productivity and Activity Impairment questionnaire across informal caregivers of chronically ill older patients. Value Health, 12(6), 1011-1017.
25. Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in cardiovascular outcomes. Circulation, 119(23), 3028-3035.
26. Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006). Effect of medication non-adherence on hospitalization and mortality among patients with diabetes mellitus. Archives of Internal Medicine, 166(17), 1836-1841.
27. Ho, P. M., Spertus, J. A., Madoudi, F. A., Reid, K. J., Peterson, E. D., Magid, D. J., Krumholz, H. M., & Rumsfeld, J. S. (2006). Impact of medication therapy discontinuation on mortality after myocardial infarction. Archives of Internal Medicine, 166(17), 1842-1847.
28. Katon, W. J., Rutter, C., Simon, G., Lin, E. H. B., Ludman, E., Ciechanowski, P., ... Von Korff, M. (2005). The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care, 28(11), 2668-2672.
29. Lewis, L. M. (2012). Factors associated with medication adherence in hypertensive blacks: A review of the literature. Journal of Cardiovascular Nursing, 27(3), 208-219.
30. Lin, E. H., Rutter, C. M., Katon, W., Heckbert, S. R., Ciechanowski, P., Oliver, M. M. ...vonKorff, M. (2010). Depression and advanced complications of diabetes: A prospective cohort study. Diabetes Care, 33(2), 264-269.
31. Ma, A. M., Barone, J., Wallis, A. E., Wu, N. J., Garcia, L. B., Estabrook, A., ... Tartter, P. I. (2008). Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. The American Journal of Surgery, 196(4), 500-504.
32. McCarthy, R. (1998). The price you pay for the drug not taken. Business Health, 16(10), 27-28, 30, 32-33.
33. McHorney, C. (2009). The adherence estimator: A brief proximal screener for patient propensity to adhere to prescription medications for chronic disease. Current Medical Research and Opinion, 25, 215-238.
34. MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. (2005). Assessing medication adherence in the elderly: Which tools to use in clinical practice? Drugs and Aging, 22(3), 231-255.
35. Morisky, D. E., Ang, A., Krousel-Wood, M. A., & Ward, H. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10, 348-354.
36. Munger, M. A., Van Tassell, B. W., & LaFleur, J. (2007). Medication non-adherence: An unrecognized cardiovascular risk factor. Medscape General Medicine, 9(3), 58.
37. Murray, M. D., Morrow, D. G., Weiner, M., Clark, D. O., Tu, W., Deer, M. M., ...Weinberger, M. (2004). A conceptual framework to study medication adherence in older adults. The American Journal of Geriatric Pharmacotherapy, 2(1), 36-43.
38. O'Connor, P. J. (2006). Improving medication adherence: Challenges for physicians, payers, and policy makers. Archives of Internal Medicine, 166(17), 1802-1804.
39. Osterberg, L., & T. Blaschke (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487-497.
40. Raebel, M. A., Carroll, N., Ellis, J., Schroeder, E., & Bayliss, E. (2011). Importance of including early non-adherence in estimations of medication adherence. Annals of Pharmacotherapy, 45(9), 1053-1060.
41. Rasmussen, J. N., Chong, A., & Alter, D. A. (2007). Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Journal of American Medical Association, 297(2), 177-186.
42. Reginster, J. Y., Rabenda, V., & Neuprez, A. (2006). Adherence, patient preference and dosing frequency: Understanding the relationship. Bone, 38(4 Suppl. 1), S2-S6.
43. Roebuck, M. C., Libeman, J., Gemmill-Toyama, & Brennan, T. (2011). Medication adherence leads to lower health care use and despite increased drug spending. Health Affairs, 30(1), 91-99.
44. Rolley, J. X., Davidson, P. M., Dennison, C. R., Ong, A., Everett, B., & Salamonson, Y. (2008). Medication adherence self-report instruments: Implications for practice and research. Journal of Cardiovascular Nursing, 23(6), 497-505.
45. Shi, L., Liu, J., Koleva, Y., Fonseca, V., Kalsekar, A., & Pawaskar, M. (2010). Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics, 28(12), 1097-1107.
46. Smolen, A. (2010). Medication therapy management: Recommending generic drugs as cost-savings substitutes. U.S. Pharmacist, 35(6), 22-28. Retrieved from http://www.uspharmacist.com/content/s/127/c/21065/
47. Spertus, J. A., Kettelkamp, R., Vance, C., Decker, C., Jones, P., Rumsfield, J., ...Cohen, D. J. (2006). Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation, 113(24), 2803-2809.
48. Velligan, D. I., Lam, Y. F., Glahn, D. C., Barrett, J. A., Maples, N. J., Ereshefsky, L., & Miller, A. L. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry, 70(Suppl. 4), 1-46; quiz 47-48.
49. Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., & Blumenthal, D. (2007). Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine, 22(Suppl. 3), 391-395.
50. Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., & Burnier, M. (2008). Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories. British Medical Journal, 336, 1114-1117.
51. World Health Organization. (2003). Adherence to long term therapies: Evidence for action. Geneva, Switzerland: Author.
52. Wolff, J. L., et al. (2010). Effects of guided care on family caregivers. The Gerontologist, 50(4), 459-470.
53. Zivin, K., & Kales, H. C. (2008). Adherence to depression treatment in older adults: A narrative review. Drugs and Aging, 25(7), 559-571.